• Advancing R&D for chronic diseases with AI: A conversation with Novo Nordisk’s CSO

  • 2024/09/18
  • 再生時間： 26 分
  • ポッドキャスト

Advancing R&D for chronic diseases with AI: A conversation with Novo Nordisk’s CSO

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Marcus Schindler, chief scientific officer, and head of research and early development at Novo Nordisk, shares the ways in which he's leading the company’s efforts to embrace external innovation and expand into new therapeutic areas with AI as a powerful catalyst for progress with McKinsey colleagues Alex Devereson and Nav Nagra.

    Learn more about the McKinsey R&D practice here.

    See www.mckinsey.com/privacy-policy for privacy information
    続きを読む 一部表示

あらすじ・解説

Marcus Schindler, chief scientific officer, and head of research and early development at Novo Nordisk, shares the ways in which he's leading the company’s efforts to embrace external innovation and expand into new therapeutic areas with AI as a powerful catalyst for progress with McKinsey colleagues Alex Devereson and Nav Nagra.

Learn more about the McKinsey R&D practice here.

See www.mckinsey.com/privacy-policy for privacy information
続きを読む 一部表示

Advancing R&D for chronic diseases with AI: A conversation with Novo Nordisk’s CSOに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。